LDR is a global medical device company focused on designing and marketing innovative and proprietary surgical technologies for the treatment of patients suffering from spinal disorders. Products developed by LDR are less invasive, provide greater intra-operative flexibility, offer simplified surgical techniques and promote improved clinical outcomes for patients as compared to existing alternatives. LDR is listed on the Nasdaq Global Market (ticker symbol “LDRH”). Keensight Capital provided an equity investment to finance clinical studies in the USA and prepare the company for a Nasdaq IPO.
Investors 1
| Date | Name | Website |
| 17.07.2021 | Keensight ... | keensightc... |